Mobile Healthcare Services has launched in Massachusetts, offering a variety of customized COVID-19 testing program options and conducting more than 30,000 mobile COVID-19 tests per month to help mitigate the spread of the novel coronavirus.
Mobile Healthcare Services (MHS) has launched in Massachusetts, offering a variety of customized COVID-19 testing program options and conducting more than 30,000 mobile COVID-19 tests per month to help mitigate the spread of the novel coronavirus.
In response to the great need for testing during the pandemic, the MHS team of healthcare experts, in conjunction with a world-class laboratory in Boston, created customized COVID-19 testing programs to meet the needs of a wide range of companies and facilities. MHS offers turnkey solutions to manage the logistics, implementation and operation of a testing program so businesses can focus on their day-to-day operations, according to a release.
Through this initiative, MHS is bridging gaps in healthcare accessibility by providing tools, including policies, procedures, best practices, educational resources for administrative staff, specimen collection services, kits and all the necessary supplies to perform COVID-19 testing.
Registered nurses, EMTs and paramedics in full PPE perform on-site sample collection at any desired location within New England. MHS ensures secure, confidential, online results are available between 24 to 48 hours after testing. MHS also guarantees the cost of their testing solution will be among the lowest PCR COVID-19 testing options on the market and of the highest quality.
"Having mobile COVID-19 testing has been a critical component for our organization to continue to safely offer our essential mental health and human services during this challenging time,” said Noreen Hayes, assistant director of human resources for ServiceNet, in the release. "Partnering with Mobile Healthcare Services eliminates the stress of managing the complexities of a testing program, and we can feel confident that our employees, individuals and families are receiving the highest level of care from an experienced team of healthcare providers."
MHS was created to utilize the unique skillset of EMTs, paramedics and field providers who are accustomed to delivering care on-the-go. By leveraging idle time experienced between ambulance calls, MHS is able to provide much needed care in the convenience and comfort of patients’ homes, workplaces or live-in care facilities.
“Mobile Healthcare Services recognizes that healthcare is changing, and it no longer exists solely within the four walls of hospitals, medical office buildings and clinics,” said Alexandre Theoharidis, President and CEO of Mobile Healthcare Services, in the release. “At MHS, we combine the powerful knowledge and experience of field providers with the latest technology innovations in the market to conquer the last mile in healthcare, and bring care to the patient, which is more important than ever as communities look to mitigate the spread of COVID-19.”
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More